% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Bidaud:153375,
author = {Bidaud, Isabelle and Chong, Antony Chung You and Carcouet,
Agnes and Waard, Stephan De and Charpentier, Flavien and
Ronjat, Michel and Waard, Michel De and Isbrandt, Dirk and
Wickman, Kevin and Vincent, Anne and Mangoni, Matteo E and
Mesirca, Pietro},
title = {{I}nhibition of {G} protein-gated {K}+ channels by
tertiapin-{Q} rescues sinus node dysfunction and
atrioventricular conduction in mouse models of primary
bradycardia.},
journal = {Scientific reports},
volume = {10},
number = {1},
issn = {2045-2322},
address = {[London]},
publisher = {Macmillan Publishers Limited, part of Springer Nature},
reportid = {DZNE-2020-01372},
pages = {9835},
year = {2020},
abstract = {Sinus node (SAN) dysfunction (SND) manifests as low heart
rate (HR) and is often accompanied by atrial tachycardia or
atrioventricular (AV) block. The only currently available
therapy for chronic SND is the implantation of an electronic
pacemaker. Because of the growing burden of SND in the
population, new pharmacological therapies of chronic SND and
heart block are desirable. We developed a collection of
genetically modified mouse strains recapitulating human
primary SND associated with different degrees of AV block.
These mice were generated with genetic ablation of L-type
Cav1.3 (Cav1.3-/-), T-type Cav3.1 (Cav3.1-/-), or both
(Cav1.3-/-/Cav3.1-/-). We also studied mice
haplo-insufficient for the Na+ channel Nav1.5 (Nav1.5+/) and
mice in which the cAMP-dependent regulation of
hyperpolarization-activated f-(HCN4) channels has been
abolished (HCN4-CNBD). We analysed, by telemetric ECG
recording, whether pharmacological inhibition of the
G-protein-activated K+ current (IKACh) by the peptide
tertiapin-Q could improve HR and AV conduction in these
mouse strains. Tertiapin-Q significantly improved the HR of
Cav1.3-/- $(19\%),$ Cav1.3-/-/Cav3.1-/- $(23\%)$ and
HCN4-CNBD $(14\%)$ mice. Tertiapin-Q also improved cardiac
conduction of Nav1.5+/- mice by $24\%.$ Our data suggest
that the development of pharmacological IKACh inhibitors for
the management of SND and conduction disease is a viable
approach.},
keywords = {Animals / Bee Venoms: pharmacology / Bradycardia:
metabolism / Bradycardia: physiopathology / Calcium
Channels, L-Type: metabolism / Disease Models, Animal /
GTP-Binding Proteins: metabolism / Heart Conduction System:
drug effects / Heart Rate: drug effects / Mice / NAV1.5
Voltage-Gated Sodium Channel: metabolism / Potassium Channel
Blockers: pharmacology / Potassium Channels: metabolism /
Sinoatrial Node: drug effects / Sinoatrial Node:
physiopathology},
cin = {AG Isbrandt},
ddc = {600},
cid = {I:(DE-2719)1011003},
pnm = {342 - Disease Mechanisms and Model Systems (POF3-342)},
pid = {G:(DE-HGF)POF3-342},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:32555258},
pmc = {pmc:PMC7300035},
doi = {10.1038/s41598-020-66673-8},
url = {https://pub.dzne.de/record/153375},
}